» Articles » PMID: 26558437

OASIS Modulates Hypoxia Pathway Activity to Regulate Bone Angiogenesis

Overview
Journal Sci Rep
Specialty Science
Date 2015 Nov 13
PMID 26558437
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

OASIS/CREB3L1, an endoplasmic reticulum (ER)-resident transcription factor, plays important roles in osteoblast differentiation. In this study, we identified new crosstalk between OASIS and the hypoxia signaling pathway, which regulates vascularization during bone development. RT-PCR and real-time PCR analyses revealed significant decreases in the expression levels of hypoxia-inducible factor-1α (HIF-1α) target genes such as vascular endothelial growth factor A (VEGFA) in OASIS-deficient (Oasis(-/-)) mouse embryonic fibroblasts. In coimmunoprecipitation experiments, the N-terminal fragment of OASIS (OASIS-N; activated form of OASIS) bound to HIF-1α through the bZIP domain. Luciferase assays showed that OASIS-N promoted the transcription activities of a reporter gene via a hypoxia-response element (HRE). Furthermore, the expression levels of an angiogenic factor Vegfa was decreased in Oasis(-/-) osteoblasts. Immunostaining and metatarsal angiogenesis assay showed retarded vascularization in bone tissue of Oasis(-/-) mice. These results suggest that OASIS affects the expression of HIF-1α target genes through the protein interaction with HIF-1α, and that OASIS-HIF-1α complexes may play essential roles in angiogenesis during bone development.

Citing Articles

Activation of the osteoblastic HIF-1α pathway partially alleviates the symptoms of STZ-induced type 1 diabetes mellitus via RegIIIγ.

Qiu M, Chang L, Tang G, Ye W, Xu Y, Tulufu N Exp Mol Med. 2024; 56(7):1574-1590.

PMID: 38945950 PMC: 11297314. DOI: 10.1038/s12276-024-01257-4.


The Regulatory Network of CREB3L1 and Its Roles in Physiological and Pathological Conditions.

Zhao Y, Yu Z, Song Y, Fan L, Lei T, He Y Int J Med Sci. 2024; 21(1):123-136.

PMID: 38164349 PMC: 10750332. DOI: 10.7150/ijms.90189.


Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens.

Seetharam S, Liu Y, Wu J, Fechter L, Murugesan K, Maecker H Blood Adv. 2023; 7(18):5433-5445.

PMID: 37315179 PMC: 10509670. DOI: 10.1182/bloodadvances.2022008939.


Hypoxia Pathway in Osteoporosis: Laboratory Data for Clinical Prospects.

Wang J, Zhao B, Che J, Shang P Int J Environ Res Public Health. 2023; 20(4).

PMID: 36833823 PMC: 9963321. DOI: 10.3390/ijerph20043129.


Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens.

Seetharam S, Liu Y, Wu J, Fechter L, Murugesan K, Maecker H bioRxiv. 2023; .

PMID: 36712071 PMC: 9881897. DOI: 10.1101/2023.01.07.523111.


References
1.
Omori Y, Imai J, Watanabe M, Komatsu T, Suzuki Y, Kataoka K . CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. Nucleic Acids Res. 2001; 29(10):2154-62. PMC: 55463. DOI: 10.1093/nar/29.10.2154. View

2.
Jiang H, Guo R, Powell-Coffman J . The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia. Proc Natl Acad Sci U S A. 2001; 98(14):7916-21. PMC: 35443. DOI: 10.1073/pnas.141234698. View

3.
Tombran-Tink J, Barnstable C . Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone. Biochem Biophys Res Commun. 2004; 316(2):573-9. DOI: 10.1016/j.bbrc.2004.02.076. View

4.
Zelzer E, Mamluk R, Ferrara N, Johnson R, Schipani E, Olsen B . VEGFA is necessary for chondrocyte survival during bone development. Development. 2004; 131(9):2161-71. DOI: 10.1242/dev.01053. View

5.
Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert S . The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007; 117(6):1616-26. PMC: 1878533. DOI: 10.1172/JCI31581. View